Why Healthcare Stocks Face a Rocky Road in Congress

A shift in power creates waves on Wall Street. Big healthcare firms face new hurdles as a new Congress takes charge.

Lawmakers want to lower drug costs and shift health policy. These moves can cut into company profits. Many medical firms gain speed during quiet times, but new debates slow their momentum.

Smart investors watch Washington closely during these shifts. Leaders plan to question high prices in public hearings. Strong businesses will still adapt and find ways to grow.

Keep a balanced portfolio while leaders debate the rules. Look for firms with strong balance sheets and steady cash. These reliable names handle political noise with ease.

Source: CNBC